Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cytek Biosciences (CTKB) Inventory Average (2021 - 2026)

Cytek Biosciences filings provide 5 years of Inventory Average readings, the most recent being $50.0 million for Q4 2025.

  • On a quarterly basis, Inventory Average rose 10.35% to $50.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $50.0 million, a 10.35% increase, with the full-year FY2025 number at $46.2 million, down 11.88% from a year prior.
  • Inventory Average hit $50.0 million in Q4 2025 for Cytek Biosciences, down from $50.6 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $67.6 million in Q2 2023 to a low of $27.1 million in Q3 2021.
  • Median Inventory Average over the past 5 years was $48.6 million (2022), compared with a mean of $49.1 million.
  • Biggest five-year swings in Inventory Average: soared 74.86% in 2022 and later dropped 29.01% in 2024.
  • Cytek Biosciences' Inventory Average stood at $29.8 million in 2021, then surged by 63.4% to $48.8 million in 2022, then soared by 31.0% to $63.9 million in 2023, then dropped by 29.01% to $45.3 million in 2024, then rose by 10.35% to $50.0 million in 2025.
  • The last three reported values for Inventory Average were $50.0 million (Q4 2025), $50.6 million (Q3 2025), and $47.4 million (Q2 2025) per Business Quant data.